Skip to main content


Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Figure 1 | Cancer Cell International

Figure 1

From: A new concept for cancer therapy: out-competing the aggressor

Figure 1

The time series schematic depicts the growth of the red, therapeutically engineered (tumor) cell clone within a native (grey) tumor cell population (patterning represents inhomogeneity of the cell population). Once the altered clone dominates the tumor population on site, it could be selectively therapeutically targeted.

Back to article page